Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

Cancer is still one of the world's most feared diseases, tragically affecting millions of lives through diagnosis, treatment ...

When Jayant Parthasarathy lost family members to breast, brain, ovarian, and prostate cancers, his next mission was clear.

Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my PSA went up; what does that mean?” ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer ...

A full-body scan every few years, for some, is a small price to pay for a wide-ranging check-up. Is it the right choice for ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

State Sen. Don DeWitte announced Monday that he is being treated for prostate cancer but expects to be back at work in the ...